[go: up one dir, main page]

AU7604194A - Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine - Google Patents

Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine

Info

Publication number
AU7604194A
AU7604194A AU76041/94A AU7604194A AU7604194A AU 7604194 A AU7604194 A AU 7604194A AU 76041/94 A AU76041/94 A AU 76041/94A AU 7604194 A AU7604194 A AU 7604194A AU 7604194 A AU7604194 A AU 7604194A
Authority
AU
Australia
Prior art keywords
caffeine
compositions containing
inflammatory agents
steroidal anti
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76041/94A
Inventor
Sekhar Mitra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU7604194A publication Critical patent/AU7604194A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76041/94A 1993-09-07 1994-08-24 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine Abandoned AU7604194A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11738993A 1993-09-07 1993-09-07
US117389 1993-09-07
PCT/US1994/009582 WO1995007079A1 (en) 1993-09-07 1994-08-24 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine

Publications (1)

Publication Number Publication Date
AU7604194A true AU7604194A (en) 1995-03-27

Family

ID=22372657

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76041/94A Abandoned AU7604194A (en) 1993-09-07 1994-08-24 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine

Country Status (6)

Country Link
EP (1) EP0717624A1 (en)
JP (1) JPH09502202A (en)
AU (1) AU7604194A (en)
BR (1) BR9407415A (en)
CA (1) CA2170485C (en)
WO (1) WO1995007079A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US5863902A (en) * 1995-01-06 1999-01-26 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
BR9710448A (en) * 1996-05-20 1999-08-17 Searle & Co Pharmaceutical formulations of sodium potassium salt and tris oxaprozine
KR20010013712A (en) 1998-04-11 2001-02-26 엘레카빠 유로테라삐치 에스.피.에이. Pharmaceutical preparation containing hydrosoluble ketoprofen salts and their application
PL345340A1 (en) 1998-07-09 2001-12-17 Warner Lambert Co Compositions comprising gaba analogs and caffeine
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
US7863287B2 (en) 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
US9629847B2 (en) 2011-11-23 2017-04-25 Michael Leighton Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant
US9149474B2 (en) 2011-11-23 2015-10-06 Michael Leighton Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant
EP3406239B1 (en) * 2017-05-22 2021-10-20 Epifarma Srl Palatable ketoprofen lysine salt solutions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
DE3328401A1 (en) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren INJECTABLE SOLUTION FOR TREATING INFLAMMATION
AU6758990A (en) * 1989-11-06 1991-05-31 Sepracor, Inc. Analgesic composition containing optically pure s(+) flurbiprofen
US4994604A (en) * 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
JPH08501796A (en) * 1992-09-29 1996-02-27 メルク エンド カンパニー インコーポレーテッド Ibuprofen-caffeine formulation
BR9307697A (en) * 1992-12-21 1999-05-25 Procter & Gamble Compositions containing caffeine and s (+) - ibuprofen or s (+) - flubiprofen or s (+) - quetoprofen
WO1994016703A1 (en) * 1993-01-29 1994-08-04 Merck & Co., Inc. Ciclobenzaprine-caffeine combination as a muscle relaxant

Also Published As

Publication number Publication date
CA2170485C (en) 2000-11-07
JPH09502202A (en) 1997-03-04
BR9407415A (en) 1996-11-12
CA2170485A1 (en) 1995-03-16
EP0717624A1 (en) 1996-06-26
WO1995007079A1 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
AU7690794A (en) Acylpyrrole-alkanoic acids and indole-2-alkanoic acids plus their derivatives for use as inhibitors of phospholipase a2
AU6447294A (en) Effervescent formulations of base coated acid particles
PL337698A1 (en) Derivatives of 4-bromo- or iodo-phenylaminobenzhydroxamic acid and their application as mek inhibitors
EP0821054A3 (en) Use of polyaspartic acids and their salts
AU7294194A (en) Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
AU7672294A (en) Compositions and methods for the administration of delta-aminolevulinic acid
IL128600A0 (en) Propionic acid derivatives and pharmaceutical compositions containing them
NZ250762A (en) Five-membered-heterocyclic carboxylic acid derivatives and pharmaceutical compositions
AU1025792A (en) Amino acid derivatives
AU2394795A (en) Hydroxamic acid and amino acid derivatives and their use as anti-arthritic agents
AU6359594A (en) Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
AU3261193A (en) Amino acid derivatives as paf-receptor antagonists
AU6049696A (en) Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
AU7604194A (en) Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
PL330482A1 (en) Novel amino acid derivatives and their application as thrombosin inhibitors
AU6518394A (en) Paint solvent formulations and methods of use
AU4077193A (en) Alpha-aminoboronic acid peptides and their use as elastase inhibitors
AU2626895A (en) Production and uses of caffeic acid and derivatives thereof
AU2111095A (en) Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them
AU5825194A (en) Novel amino acid derivatives
AU3407597A (en) Useful formulations of acid addition salt drugs
AU5050198A (en) Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors
AU4532893A (en) Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
AU1240995A (en) Use of phenyl carboxilic acid amides as crystalisation inhibitors
AU7476494A (en) Use of n-methyl-aspartic acid for enhancing growth and altering body composition